Perimenopause and Autoimmune Conditions: Managing Overlapping Symptoms
How hormonal changes during perimenopause affect autoimmune conditions like lupus, MS, and rheumatoid arthritis. Specialist care and coping strategies.
The Oestrogen-Immune System Connection
Oestrogen is a powerful immune modulator. It influences the activity of T cells, B cells, and natural killer cells, and it plays a role in the production of antibodies and cytokines. This is one reason why women are significantly more likely than men to develop autoimmune diseases. Oestrogen tends to promote immune reactivity, which may contribute to autoimmune vulnerability in general, but it also performs regulatory functions that help keep excessive inflammation in check. During perimenopause, as oestrogen levels become erratic and then decline, this finely tuned immune regulation is disrupted. The result is that many women with established autoimmune conditions notice meaningful changes in their disease activity during the perimenopausal transition. Some experience flares. Others find unexpected periods of remission. The pattern is individual and unpredictable, which makes careful monitoring and open communication with your specialist team essential during these years.
Rheumatoid Arthritis and Hormonal Shifts
Rheumatoid arthritis is one of the autoimmune conditions most clearly influenced by hormonal changes. Many women with RA notice that the perimenopausal transition brings increased joint inflammation, greater morning stiffness, and a higher frequency of flares. Disease-modifying anti-rheumatic drugs that previously maintained remission may feel less effective. This is not always a sign that treatment needs to change fundamentally, but it does warrant a review with your rheumatologist to assess current disease activity using blood markers and clinical examination. There is emerging evidence that HRT may have a beneficial effect on RA activity, likely through its anti-inflammatory properties, though individual responses vary. From a lifestyle perspective, anti-inflammatory eating, sleep optimisation, and appropriate exercise all support better RA management during perimenopause. Avoid framing increased symptoms as failure. They are a physiological response to hormonal change, and they can be addressed with the right clinical support.
Lupus During Perimenopause
Systemic lupus erythematosus has a complex relationship with oestrogen. Because oestrogen tends to be immunostimulatory, many women with lupus have been historically advised to avoid oestrogen-containing HRT. However, more recent research has refined this guidance considerably. For women with well-controlled lupus and no history of antiphospholipid antibodies or blood clotting issues, HRT may be considered safe and beneficial for managing perimenopausal symptoms and protecting bone density. This decision must be made collaboratively with a rheumatologist and menopause specialist who can review your specific antibody profile, disease activity score, and cardiovascular risk. Women with lupus are already at elevated cardiovascular risk, and oestrogen loss accelerates this further, so the conversation about HRT is worth having rather than assuming it is off the table. Regular monitoring, including urine protein checks, kidney function, and inflammatory markers, is important throughout perimenopause regardless of HRT decisions.
Multiple Sclerosis and the Perimenopausal Transition
Women with multiple sclerosis often report that their symptoms shift meaningfully during perimenopause. Heat sensitivity, fatigue, cognitive symptoms, and bladder issues, all of which are common in MS, may intensify as oestrogen declines. Oestrogen has neuroprotective properties and influences myelin integrity, so hormonal fluctuations may affect neurological function in ways that feel distinct from a standard MS relapse. Distinguishing a perimenopausal aggravation of MS symptoms from an actual relapse is clinically important and may require neurological assessment. Some women with MS and their neurologists consider HRT as a potential neuroprotective strategy, though evidence is still building in this area. The practical priorities during this period include managing fatigue carefully through pacing and sleep hygiene, staying cool to manage heat sensitivity, addressing any bladder symptoms proactively, and ensuring your GP is communicating with your neurology team so that both conditions are seen in context.
Building the Right Specialist Team
Managing perimenopause alongside an autoimmune condition works best with a team-based approach. Your core team might include your GP, a rheumatologist or neurologist depending on your condition, and a menopause specialist, ideally one with experience in complex medical histories. Some women also benefit from input from a dietitian who understands both anti-inflammatory nutrition and menopausal metabolic changes, and a physiotherapist who can design exercise programmes that respect disease activity limits while building strength and resilience. If your current GP is not familiar with the intersection of perimenopause and autoimmune disease, consider asking for a referral to a British Menopause Society accredited clinic, where clinicians are trained to manage exactly these complexities. Advocate for shared care letters so that all your clinicians have the same information. You are not being difficult by requesting coordinated care. You are being appropriately thorough about a genuinely complex clinical situation.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.